DeepMed Research

Peking University First Hospital (Peking Univesity First Medical School)

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation

Not Applicable

Completed

Conditions: Liver Cancer
Radiofrequency Ablation
Esketamine
Dexmedetomidine

Interventions: Drug: Dexmedetomidine-esketamine combination
Drug: Remifentanil
Drug: Oxycodone

First Posted Date: 2023-08-21

Last Posted Date: 2025-04-02

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 88

Registration Number: NCT06003218

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.

Phase 4

Recruiting

Conditions: Coronary Microvascular Dysfunction

Interventions: Drug: standard heparin
Drug: Bivalirudin

First Posted Date: 2023-08-09

Last Posted Date: 2024-04-02

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 70

Registration Number: NCT05984537

Locations: 🇨🇳
Peking university first hospital, Beijing, Beijing, China

Early Warning Value of Consumer Wearable Devices in AECOPD

Recruiting

Conditions: COPD

Interventions: Device: Consumer wearable device

First Posted Date: 2023-08-03

Last Posted Date: 2023-08-03

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 150

Registration Number: NCT05974670

Locations: 🇨🇳
Beijing Miyun Hospital, Beijing, Beijing, China
🇨🇳
Shichahai Community Health Service Center, Beijing, Beijing, China
🇨🇳
Aerospace 731 Hospital, Beijing, Beijing, China

and more 4 locations

A Novel Equation for Estimating Sodium Intake in Peritoneal Dialysis.

Not yet recruiting

Conditions: Dietary Sodium Intake

First Posted Date: 2023-07-21

Last Posted Date: 2023-07-27

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 40

Registration Number: NCT05955417

Mini-dose Dexmedetomidine-Esketamine Infusion and Perioperative Sleep Quality

Phase 4

Recruiting

Conditions: Hip Replacement Surgery
Old Age
Knee Replacement Surgery
Dexmedetomidine
Esketamine
Sleep Quality

Interventions: Drug: Normal saline
Drug: Dexmedetomidine
Drug: Esketamine

First Posted Date: 2023-07-18

Last Posted Date: 2023-11-24

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 154

Registration Number: NCT05950646

Locations: 🇨🇳
Beijing Hospital, Beijing, Beijing, China
🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Effect of Urine-guided Hydration on Acute Kidney Injury After CRS-HIPEC

Not Applicable

Completed

Conditions: Cytoreductive Surgery
Hyperthermic Intraperitoneal Chemotherapy
Hydration
Diuresis
Acute Kidney Injury
Postoperative Complications

Interventions: Procedure: Routine hydration
Procedure: Urine-guided hydration
Drug: Forced administration of furosemide
Drug: Routine administration of furosemide

First Posted Date: 2023-07-11

Last Posted Date: 2025-03-19

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 168

Registration Number: NCT05939193

Locations: 🇨🇳
Aerospace Center Hospital, Beijing, China

68Ga-P3 PET/CT Imaging in Prostate

Not Applicable

Recruiting

Conditions: Neoplasms

Interventions: Drug: [68Ga]P3

First Posted Date: 2023-07-11

Last Posted Date: 2024-11-07

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 30

Registration Number: NCT05940259

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

MRI Study of Blood-brain Barrier Function in CADASIL

Recruiting

Conditions: Blood Brain Barrier Defect
Cadasil

Interventions: Other: MRI

First Posted Date: 2023-06-13

Last Posted Date: 2023-06-13

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 100

Registration Number: NCT05902039

Locations: 🇨🇳
Peking University First Hospital, Beijing, China

68Ga-P3 PET/CT Imaging in Malignancy

Not Applicable

Recruiting

Conditions: Neoplasms

Interventions: Drug: [68Ga]P3

First Posted Date: 2023-06-05

Last Posted Date: 2024-11-07

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 350

Registration Number: NCT05887687

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Phase 4

Recruiting

Conditions: Vitamin D Deficiency
Peritoneal Dialysis-associated Peritonitis

Interventions: Drug: Cholecalciferol
Drug: Placebo

First Posted Date: 2023-05-16

Last Posted Date: 2024-08-06

Lead Sponsor: Peking University First Hospital

Target Recruit Count: 176

Registration Number: NCT05860270

Locations: 🇨🇳
Peking University First Hospital, Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy